成纖維細(xì)胞是來(lái)源于胚胎中胚層的間充質(zhì)細(xì)胞，是*容易體外培養(yǎng)的細(xì)胞之一，廣泛應(yīng)用于許多細(xì)胞學(xué)和生物學(xué)研究。它們的耐用性也使它們適用于從細(xì)胞轉(zhuǎn)染到顯微注射的各種操作。它們負(fù)責(zé)在結(jié)締組織中細(xì)胞外基質(zhì)的合成，并在傷口愈合中發(fā)揮核心作用。成纖維細(xì)胞可分泌富含I型和/或III型膠原的非剛性細(xì)胞外基質(zhì)。人膀胱基質(zhì)成纖維細(xì)胞也可分泌主要與膀胱上皮細(xì)胞作用的FGF-7。FGF-7對(duì)多層膀胱上皮形成的刺激作用很重要。
Sciencell研究實(shí)驗(yàn)室的人膀胱微血管內(nèi)皮細(xì)胞是從人膀胱組織中分離得到的，一代凍存，冰凍運(yùn)輸。每管細(xì)胞密度超過(guò)5×10^5/ml。該細(xì)胞可通過(guò)纖連蛋白的免疫熒光鑒定。本細(xì)胞經(jīng)檢測(cè)不含HIV-1、HBV、HCV、支原體、細(xì)菌、酵母菌和真菌。如采用ScienCell 實(shí)驗(yàn)室特制的培養(yǎng)基，可保證此細(xì)胞15倍增殖。

推薦培養(yǎng)基：尿道上皮細(xì)胞培養(yǎng)基 (UMC, Cat. #4321)

貨號(hào)	4320
產(chǎn)地	美國(guó)
縮寫(xiě)	HUC
規(guī)格	5 x 10^5/1ml
用途	科研
儲(chǔ)存	液氮
運(yùn)輸	干冰
關(guān)鍵字	人尿道上皮細(xì)胞 HUC 人尿道上皮細(xì)胞 HUC 人尿道上皮細(xì)胞 HUC 人尿道上皮細(xì)胞 HUC 人尿道上皮細(xì)胞 HUC 人尿道上皮細(xì)胞 HUC
公司簡(jiǎn)介	合肥星肽生物科技有限公司作為專(zhuān)業(yè)的ScienCell中國(guó)代理商，專(zhuān)業(yè)經(jīng)營(yíng)實(shí)驗(yàn)室科研用原代細(xì)胞、原代細(xì)胞專(zhuān)用培養(yǎng)基、原代細(xì)胞無(wú)血清培養(yǎng)基、干細(xì)胞、干細(xì)胞培養(yǎng)基、干細(xì)胞無(wú)血清培養(yǎng)基的研究和開(kāi)發(fā)。合肥星肽生物科技有限公司始終致力于為客戶(hù)提供可靠的研究材料以及方便快捷的服務(wù)，對(duì)購(gòu)買(mǎi)項(xiàng)目的前期資料提供,中期合同保證,后期貨物跟蹤到終售后的確保項(xiàng)目準(zhǔn)確到位，都有相關(guān)專(zhuān)業(yè)人士進(jìn)行維護(hù),確保您在合肥合肥星肽生物科技有限公司公司獲得上等服務(wù)！
聯(lián)系方式	何經(jīng)理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898， E-mail：info@qingbio.com http://www.k85n.com QQ:514713116

1.) Lu C, Lin M, Chen S, Shen C, Chen L, Hsieh H, Chan MWY, Hsu C. (2013) "The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder." BMC Complement Altern Med. 13: 44.

2.) Marentette JO, Hauser PJ, Hurst RE, Klumpp DJ, Rickard A, McHowat J. (2013) "Tryptase activation of immortalized human urothelial cell mitogen-activated protein kinase." PLoS One. 8: e69948.

3.) Noguchi S, Yamada N, Kumazaki M, Yasui Y, Iwasaki J, Naito S, Akao Y. (2013) "socs7, a target gene of microRNA-145, regulates interferon-? induction through STAT3 nuclear translocation in bladder cancer cells." Cell Death Dis. 4: e482.

4.) Lee WY, Savage JR, Zhang J, Jia W, Oottamasathien S, Prestwich GD. (2013) "Prevention of Anti-microbial Peptide LL-37-Induced Apoptosis and ATP Release in the Urinary Bladder by a Modified Glycosaminoglycan." PloS one. 8: e77854.

5.) Tsang M, Chun YW, Im YM, Khang D, Webster TJ. (2011) "Effects of increasing carbon nanofiber density in polyurethane composites for inhibiting bladder cancer cell functions." Tissue Eng Part A. 17: 1879-89.

6.) Bhattacharya A, Tang L, Li Y, Geng F, Paonessa JD, Chen SC, Wong MK, Zhang Y. (2010) "Inhibition of bladder cancer development by allyl isothiocyanate."Carcinogenesis. 31: 281-6.

7.) Koizumi T, Nakatsuji H, Fukawa T, Avirmed S, Fukumori T, Takahashi M, Kanayama H. (2010) "The role of actinin-4 in bladder cancer invasion." Urology. 75: 357-64.

8.) Stone R 2nd, Sabichi AL, Gill J, Lee IL, Adegboyega P, Dai MS, Loganantharaj R, Trutschl M, Cvek U, Clifford JL. (2010) "Identification of genes correlated with early-stage bladder cancer progression." Cancer Prev Res (Phila). 3: 776-86.

9.) Chun YW, Khang D, Haberstroh KM, Webster TJ. (2009) "The role of polymer nanosurface roughness and submicron pores in improving bladder urothelial cell density and inhibiting calcium oxalate stone formation." Nanotechnology. 20: 085104.

產(chǎn)品留言

標(biāo)題

聯(lián)系人

聯(lián)系電話(huà)

內(nèi)容

驗(yàn)證碼